[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-368423-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-368423-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","analysis-of-the-direct-medical-costs-of-colorectal-cancer-in-antigua-and-barbuda-a-prevalence-based-cost-of-illness-study","Analysis of the Direct Medical Costs of Colorectal Cancer in Antigua and Barbuda - A Prevalence-Based Cost-of-Illness Study","","Colorectal cancer burden poses a threat to health systems in multiple countries, yet diagnosing, treating, and managing costs remain insufficiently quantified in Antigua and Barbuda. A prevalence-based cost-of-illness approach estimated the direct medical cost of colorectal cancer using patient data from diagnoses between 2017 and 2021. A five-year prevalence was derived from data-record abstraction, and both top-down and bottom-up methods were applied to cost colorectal care components. Costs were valued at 2021 price levels and reported in USD.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/analysis-of-the-direct-medical-costs-of-colorectal-cancer-in-antigua-and-barbuda-a-prevalence-based-cost-of-illness-study/368423/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/analysis-of-the-direct-medical-costs-of-colorectal-cancer-in-antigua-and-barbuda-a-prevalence-based-cost-of-illness-study/368423.png","ImageObject",300,407,{"name":42,"@type":43},"\tJames","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-01","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",5,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the aim of the study in Antigua and Barbuda?","Question",{"text":63,"@type":64},"To estimate the direct medical cost of colorectal cancer in Antigua and Barbuda where such costs were unknown.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were the direct medical costs calculated?",{"text":68,"@type":64},"Using a prevalence-based cost-of-illness methodology with a five-year prevalence, and top-down plus bottom-up approaches to cost care components.",{"name":70,"@type":61,"acceptedAnswer":71},"What time period and cost valuation standard were used?",{"text":72,"@type":64},"Patient data covered diagnoses from 2017 to 2021, and all costs were computed at 2021 price levels and reported in US dollars.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},368423,1790540324,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,100,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Comic",60,"comic",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},6,"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":55,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},2336474466412,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Article  \nAnalysis of the Direct Medical Costs of Colorectal Cancer in Antigua and Barbuda: A Prevalence-Based Cost-of-Illness Study  \nAndre A. N. Bovell 1, *, Jabulani Ncayiyana 1 and Themba G. Ginindza 1,2  \nAcademic Editor: John Øvretveit  \nReceived: 10 February 2025  \nRevised: 21 March 2025  \nAccepted: 25 March 2025  \nPublished: 3 April 2025  \nCitation: Bovell, A.A.N.; Ncayiyana, J.; Ginindza, T.G. Analysis of the Direct Medical Costs of Colorectal Cancer in Antigua and Barbuda: A PrevalenceBased Cost-of-Illness Study. Int. J. Environ. Res. Public Health 2025, 22, 552. [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)ijerph22040552  \nCopyright: © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://creativecommons.org/](https://creativecommons.org/)[ ](https://creativecommons.org/)[licenses/by/4.0/](licenses/by/4.0/)) .  \n1 Discipline of Public Health Medicine, School of Nursing and Public Health, University of KwaZulu-Natal, Durban 4000, South Africa; [ncayiyanaj@ukzn.ac.za](ncayiyanaj@ukzn.ac.za) (J.N.); [ginindza@ukzn.ac.za](ginindza@ukzn.ac.za) (T.G.G.)  \n2 Cancer & Infectious Diseases Epidemiology Research Unit (CIDERU), College of Health Sciences, University of KwaZulu-Natal, Durban 4000, South Africa  \n* Correspondence: [222081852@stu.ukzn.ac.za](222081852@stu.ukzn.ac.za); Tel.: +27-1-268-736-2389  \nAbstract: Colorectal cancer burden is a threat to health systems in several countries. As the cost of diagnosing, treating, and managing this cancer is unknown in Antigua and Barbuda, this study aimed to estimate its direct medical cost in this country. We used the prevalencebased cost-of-illness methodology to study data on patients diagnosed with colorectal cancer between 2017 and 2021 . Data record abstraction was carried out to determine the five-year prevalence, and a top-down and bottom-up approach was employed to estimate the direct medical costs for colorectal cancer care components. All costs were computed at 2021 price levels and are reported in United States dollars. The total annual direct medical costs for colorectal cancer were estimated at USD 1.14 million (ranging between USD 0.85 million and USD 1.42 million) . Major cost drivers were treatment (USD 613,650.01) and post-treatment side-effects care (USD 402,234.50) . The overall estimated direct medical unit costs were USD 139,295.58, with the main drivers being surgery (USD 43,467.10), other complications of treatment (USD 28,469.21), and immunotherapy (USD 19,200.00) . This study provides evidence of the economic burden of colorectal cancer in Antigua and Barbuda. The estimates of annual direct medical costs are substantial. Our findings could help in the development of health policy and aid in resource allocation related to local colorectal cancer management.  \nKeywords: Antigua and Barbuda; colorectal; cost-of-illness; economic burden; colon; rectum; cost analysis; cancer  \n1. Introduction  \nColorectal cancer is one of the leading cancers affecting populations globally [1,2], being the second and third most common cancer in women and men, respectively [1] . In 2022, there were an estimated 1.9 million new cases and 904,000 deaths from colorectal cancer [1], making it responsible for 9.6% of all diagnosed cancers worldwide in that year and representing a 0.2% increase from 2020’s estimate of 9.4%[1,2] .  \nKnown for its diverse risk factors, the chance of developing colorectal cancer increases markedly in patients older than 50 [3] . Notwithstanding this, recent evidence suggests a steadily rising and alarming incidence and/or increasing burden of early-onset colorectal cancer (disease in patients younger than 50 years) in several countries, especially within the last three decades [1,4] . This makes screening from as early as 45 to 50 years an important part of care in most de","cbCaik0h22SyQ2rx","https://ap.wps.com/l/cbCaik0h22SyQ2rx","pdf",3416665,23,"English","# Introduction\n## Colorectal cancer burden and risk factors\n## Treatment pathways and disease management\n## Cost-of-illness approaches and prevalence-based methodology","[{\"question\":\"What was the aim of the study in Antigua and Barbuda?\",\"answer\":\"To estimate the direct medical cost of colorectal cancer in Antigua and Barbuda where such costs were unknown.\"},{\"question\":\"How were the direct medical costs calculated?\",\"answer\":\"Using a prevalence-based cost-of-illness methodology with a five-year prevalence, and top-down plus bottom-up approaches to cost care components.\"},{\"question\":\"What time period and cost valuation standard were used?\",\"answer\":\"Patient data covered diagnoses from 2017 to 2021, and all costs were computed at 2021 price levels and reported in US dollars.\"}]","Analysis of the Direct Medical Costs of Colorectal Cancer in Antigua and Barbuda - A Prevalence-Based Cost-of-Illness Study | PDF",1790176880,58,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c3234ef079b23ab95743c168f3b7e02c.webp",983,1390,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5b50ace1126a9e541249dcb6b174648e.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e4269b32903a44d3d55069b4b6cc4fa5.webp",981,1387,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a56aff0aa70a10ecce87f8c3c14290a6.webp",980,1385]